Cargando…
Factors associated with selection of targeted therapy in patients with rheumatoid arthritis
OBJECTIVE: Deciding which drug to choose for targeted therapy is an important step in sequential treatment for rheumatoid arthritis (RA). This study aimed to identify factors for selecting Janus kinase inhibitors (JAKis) rather than biologic disease-modifying antirheumatic drugs (bDMARDs) in patient...
Autores principales: | Song, Yeo-Jin, Cho, Soo-Kyung, Kim, Hyoungyoung, Kim, Hye Won, Nam, Eunwoo, Choi, Chan-Bum, Kim, Tae-Hwan, Jun, Jae-Bum, Bae, Sang-Cheol, Yoo, Dae Hyun, Sung, Yoon Kyoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831325/ https://www.ncbi.nlm.nih.gov/pubmed/36626396 http://dx.doi.org/10.1371/journal.pone.0280234 |
Ejemplares similares
-
Risk factors for herpes zoster in Korean patients with rheumatoid arthritis treated with JAK inhibitor: a nested case–control study
por: Song, Yeo-Jin, et al.
Publicado: (2022) -
Increased risk of herpes zoster with tofacitinib treatment in Korean patients with rheumatoid arthritis: a single-center prospective study
por: Song, Yeo-Jin, et al.
Publicado: (2023) -
Risk of Tuberculosis Development in Patients with Rheumatoid Arthritis Receiving Targeted Therapy: a Prospective Single Center Cohort Study
por: Song, Yeo-Jin, et al.
Publicado: (2021) -
Drug retention and safety of TNF inhibitors in elderly patients with rheumatoid arthritis
por: Cho, Soo-Kyung, et al.
Publicado: (2016) -
Isoniazid treatment for latent tuberculosis infection is tolerable for rheumatoid arthritis patients receiving tumor necrosis factor inhibitor therapy
por: Sung, Yoon-Kyoung, et al.
Publicado: (2018)